Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
Shinya Yamanaka of Japan and John Gurdon of England have been jointly awarded the Nobel Prize in Medicine, kicking off a big for the most-coveted awards in the world.
In 1993, Japanese researcher Shinya Yamanaka was a young doctor who dreamed of becoming a research scientist -- but no one was returning his phone calls.
Two doctors from Japan and Britain have been awarded this year's Nobel Prize for Medicine for their groundbreaking work on stem cells.
John Gurdon and Shinya Yamanaka were jointly awarded the Nobel Prize in Physiology or Medicine on Monday for their research on resetting cells to their earliest developmental stages.
“Today we honor Dr. Yamanaka’s award of the prestigious Nobel Prize and his celebrated discovery of transforming adult cells to develop into any cell in the human body with boundless potential for medical advancement.
British researcher John Gurdon and Shinya Yamanaka of Japan won this year's Nobel Prize in medicine on Monday for discovering that mature, specialized cells of the body can be reprogrammed into stem cells — a discovery that scientists hope to turn into new treatments.
Shinya Yamanaka of Japan and John B. Gurdon of Britain won the Nobel Medicine Prize on Monday for their groundbreaking work on stem cells, the jury said.
Dr. Shinya Yamanaka of San Francisco's Gladstone Institutes in San Francisco won the Nobel Prize for discovering a way to turn adult human cells back into the equivalent of stem cells.
The 2012 Nobel Prize for Physiology or Medicine was awarded Monday to Sir John B. Gurdon and Shinya Yamanaka for work that revolutionized the understanding of how cells and organisms develop.
Scientists from Britain and Japan shared a Nobel Prize on Monday for the discovery that adult cells can be transformed back into embryo-like stem cells that may one day regrow tissue in damaged brains, hearts or other organs.